Company
Acumen Pharmaceuticals, Inc. (ABOS)
Standardized SEC financial data for Acumen Pharmaceuticals, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001576885 · NASDAQ · Biological Products, (No Diagnostic Substances).
Return on equity
-172.3%
Free cash flow
-$115.6M
Debt / equity
0.32×
Current ratio
4.07×
EPS (diluted)
$-2.00
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| R&D expense | $8.0M | $12.3M | $32.4M | $42.3M | $93.8M | $104.9M |
| SG&A expense |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $43.8M | $122.2M | $130.1M | $67.1M | $35.9M | $116.9M |
| Total current assets |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$7.5M | -$18.0M | -$35.2M | -$43.1M | -$86.2M | -$115.5M |
| Capital expenditures |
Get ABOS data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/ABOS/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/ABOS/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"